Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1971 Feb;8(2):319–333.

Antibodies to brain and other tissues in cases of mycoplasma pneumoniae infection

G Biberfeld
PMCID: PMC1712934  PMID: 4995565

Abstract

Complement-fixing (CF) antibodies against brain tissue antigens were demonstrated in seven cases of Mycoplasma pneumoniae infection with neurological complications. However, forty-three out of fifty-four cases (80%) without neurological symptoms also acquired antibodies to brain during the course of M. pneumoniae infection. 75% of the patients with antibodies to brain also had antibodies against human lung and liver, but the antibody titres to the latter tissue antigens were usually lower than against brain. The reactivity of M. pneumoniae antisera to brain and other tissues was significantly reduced by prior absorption with M. pneumoniae antigen, indicating the presence of a related antigen in M. pneumoniae organisms and these tissues. Fractionation by density gradient centrifugation of thirty-three sera from twenty-six cases showed the antibodies to brain to be of the IgM class exclusively in twenty-four cases while the CF antibodies to M. pneumoniae were associated with both IgM and IgG.

The brain antigen reacting in the CF test with M. pneumoniae antisera could be extracted with chloroform–methanol in the same way as the crude lipid CF antigen of M. pneumoniae.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckman B. L., Kenny G. E. Immunochemical analysis of serologically active lipids of Mycoplasma pneumoniae. J Bacteriol. 1968 Oct;96(4):1171–1180. doi: 10.1128/jb.96.4.1171-1180.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berglund A., Wikberg K. E. Komplicerande meningoencefalit vid pneumoni förorsakad av Mycoplasma pneumoniae. Lakartidningen. 1969 Jan 22;66(4):302–304. [PubMed] [Google Scholar]
  3. Biberfeld G. Distribution of antibodies within 19 S and 7 S immunoglobulins following infection with Mycoplasma pneumoniae. J Immunol. 1968 Feb;100(2):338–347. [PubMed] [Google Scholar]
  4. Biberfeld G. Mycoplasma pneumoniae infections and antibodies to brain. Lancet. 1969 Nov 29;2(7631):1202–1202. doi: 10.1016/s0140-6736(69)92530-6. [DOI] [PubMed] [Google Scholar]
  5. ENNY G. E., GRAYSTON J. T. EATON PLEUROPNEUMONIA-LIKE ORGANISM (MYCOPLASMA PNEUMONIAE) COMPLEMENT-FIXING ANTIGEN: EXTRACTION WITH ORGANIC SOLVENTS. J Immunol. 1965 Jul;95:19–25. [PubMed] [Google Scholar]
  6. Feizi T., Taylor-Robinson D., Shields M. D., Carter R. A. Production of cold agglutinins in rabbits immunized with human erythrocytes treated with Mycoplasma pneumoniae. Nature. 1969 Jun 28;222(5200):1253–1256. doi: 10.1038/2221253a0. [DOI] [PubMed] [Google Scholar]
  7. Fernald G. W., Clyde W. A., Jr, Denny F. W. Nature of the immune response to Mycoplasma pneumoniae. J Immunol. 1967 May;98(5):1028–1038. [PubMed] [Google Scholar]
  8. HAYFLICK L., CHANOCK R. M. MYCOPLASMA SPECIES OF MAN. Bacteriol Rev. 1965 Jun;29:185–221. doi: 10.1128/br.29.2.185-221.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965 Jun;23(Suppl):285+–285+. [PubMed] [Google Scholar]
  10. Lemcke R. M., Marmion B. P., Plackett P. Immunochemical analysis of Mycoplasma pneumoniae. Ann N Y Acad Sci. 1967 Jul 28;143(1):691–702. doi: 10.1111/j.1749-6632.1967.tb27715.x. [DOI] [PubMed] [Google Scholar]
  11. Lemcke R. M., Shaw E. J., Marmion B. P. Related antigens in Mycoplasma pneumoniae and Mycoplasma mycoides var. mycoides. Aust J Exp Biol Med Sci. 1965 Dec;43(6):761–770. doi: 10.1038/icb.1965.61. [DOI] [PubMed] [Google Scholar]
  12. Lind K. Immunological relationships between Mycoplasma pneumoniae and Streptococcus MG. Acta Pathol Microbiol Scand. 1968;73(2):237–244. doi: 10.1111/j.1699-0463.1968.tb00497.x. [DOI] [PubMed] [Google Scholar]
  13. MELNICK S. C. Thirty-eight cases of the Guillain-Barre syndrome: an immunological study. Br Med J. 1963 Feb 9;1(5327):368–373. doi: 10.1136/bmj.1.5327.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  15. Marmion B. P., Plackett P., Lemcke R. M. Immunochemical analysis of Mycoplasma pneumoniae. 1. Methods of extraction and reaction of fractions from M. pneumoniae and from M. mycoides with homologous antisera and with antisera against Streptococcus MG. Aust J Exp Biol Med Sci. 1967 Apr;45(2):163–187. [PubMed] [Google Scholar]
  16. Plackett P., Marmion B. P., Shaw E. J., Lemcke R. M. Immunochemical analysis of Mycoplasma pneumoniae. 3. Separation and chemical identification of serologically active lipids. Aust J Exp Biol Med Sci. 1969 Apr;47(2):171–195. doi: 10.1038/icb.1969.19. [DOI] [PubMed] [Google Scholar]
  17. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  18. Schmidt N. J., Lennette E. H., Dennis J., Gee P. S. On the nature of complement-fixing antibodies to Mycoplasma pneumoniae. J Immunol. 1966 Jul;97(1):95–99. [PubMed] [Google Scholar]
  19. Sobeslavský O., Prescott B., James W. D., Chanock R. M. Serological and immunogenic activities of different fractions of Mycoplasma pneumoniae. Ann N Y Acad Sci. 1967 Jul 28;143(1):682–690. doi: 10.1111/j.1749-6632.1967.tb27714.x. [DOI] [PubMed] [Google Scholar]
  20. Somerson N. L., James W. D., Walls B. E., Chanock R. M. Growth of Mycoplasma pneumoniae on a glass surface. Ann N Y Acad Sci. 1967 Jul 28;143(1):384–389. doi: 10.1111/j.1749-6632.1967.tb27680.x. [DOI] [PubMed] [Google Scholar]
  21. Steele J. C., Thanasophon S., Gladstone R. M., Fleming P. C. Mycoplasma pneumoniae as a determinant of the Guillain-Barré syndrome. Lancet. 1969 Oct 4;2(7623):710–714. doi: 10.1016/s0140-6736(69)90426-7. [DOI] [PubMed] [Google Scholar]
  22. Sterner G., Biberfeld G. Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis. 1969;1(3):203–208. [PubMed] [Google Scholar]
  23. THOMAS L. CIRCULATING AUTOANTIBODIES AND HUMAN DISEASE. WITH A NOTE ON PRIMARY ATYPICAL PNEUMONIA. N Engl J Med. 1964 May 28;270:1157–1159. doi: 10.1056/NEJM196405282702204. [DOI] [PubMed] [Google Scholar]
  24. TROTTER W. R., BELYAVIN G., WADDAMS A. Precipitating and complement-fixing antibodies in Hashimoto's disease. Proc R Soc Med. 1957 Nov;50(11):961–962. [PubMed] [Google Scholar]
  25. Taylor M. J., Burrow G. N., Strauch B., Horstmann D. M. Meningoencephalitis associated with pneumonitis due to Mycoplasma pneumoniae. JAMA. 1967 Mar 13;199(11):813–816. [PubMed] [Google Scholar]
  26. YESNICK L. Central nervous system complications of primary atypical pneumonia. AMA Arch Intern Med. 1956 Jan;97(1):93–98. doi: 10.1001/archinte.1956.00250190109010. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES